日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

YBX1 orchestrates LDHA-mediated metabolic reprogramming and NF-κB activation to drive clear cell renal cell carcinoma progression

YBX1通过调控LDHA介导的代谢重编程和NF-κB激活,驱动透明细胞肾细胞癌的进展。

Dong, Yihan; Qiu, Aixin; Liu, Shuang; Pan, Yuejing; Lin, Tianyu; Wang, Rui; Chen, Ruibing; Jiang, Huamao; Yu, Yang; Wang, Yong; Yue, Dan

Programmed Cell Death Protein 10 (PDCD10) Regulates Vesicle Trafficking and Contributes to the Progression of Clear Cell Renal Cell Carcinoma.

程序性细胞死亡蛋白 10 (PDCD10) 调节囊泡运输并促进透明细胞肾细胞癌的进展

Wang Rui, Lin Tianyu, Liu Yi, Wang Hao, Liu Xinyu, Dong Yihan, Li Jiaxin, Jiang Huamao, Chen Ruibing, Wang Yong, Yue Dan

ABCG1 promotes the proliferation and migration of clear cell renal cell carcinoma and reduces its apoptosis

ABCG1促进透明细胞肾细胞癌的增殖和迁移,并减少其凋亡

Dong, Yihan; Qiao, Qiufang; Guo, Shaomin; Chen, Ruibing; Lin, Tianyu; Liu, Xinyu; Li, Jiaxin; Liu, Shiming; Jiang, Huamao; Wang, Yong; Yue, Dan; Wang, Rui

Multimodal Metaverse Healthcare: A Collaborative Representation and Adaptive Fusion Approach for Generative Artificial-Intelligence-Driven Diagnosis

多模态元宇宙医疗:一种用于生成式人工智能驱动诊断的协作表征和自适应融合方法

Lv, Jianhui; Slowik, Adam; Rani, Shalli; Kim, Byung-Gyu; Chen, Chien-Ming; Kumari, Saru; Li, Keqin; Lyu, Xiaohong; Jiang, Huamao

Identification of KLHL17 as a prognostic marker for prostate cancer based on single-cell sequencing and in vitro/in vivo experiments

基于单细胞测序和体外/体内实验,鉴定出KLHL17是前列腺癌的预后标志物。

Zhou, Qingyu; Guo, Dan; Shen, Tong; Jiang, Huamao

Species-Specific Involvement of Integrin αIIbβ3 in a Monoclonal Antibody CH12 Triggers Off-Target Thrombocytopenia in Cynomolgus Monkeys

单克隆抗体 CH12 中整合素 αIIbβ3 的物种特异性参与会引发食蟹猴的脱靶血小板减少症

Yiting Zhang, Jianhua Sun, Minjia Tan, Yongzhen Liu, Qian Li, Hua Jiang, Huamao Wang, Zonghai Li, Wei Wan, Hualiang Jiang, Henglei Lu, Bingshun Wang, Jin Ren, Likun Gong